Oligonucleotide compositions and methods thereof

Abstract

Among other things, the present disclosure provides designed DMD oligonucleotides, compositions, and methods of use thereof. In some embodiments, the present disclosure provides technologies useful for repairing mutant DMD transcripts by skipping exon 51, so that the transcript can be translated into an internally truncated but at least partially functional Dystrophin protein variant. In some embodiments, the present disclosure provides technologies useful for modulating DMD transcript splicing. In some embodiments, provided technologies can alter splicing of a dystrophin (DMD) DMD transcript. In some embodiments, the present disclosure provides methods for treating diseases, such as muscular dystrophy, including but not limited to Duchenne muscular dystrophy, Becker’s muscular dystrophy, etc. 1006674573 20 26 20 60 58 14 J ul 2 02 6 A B S T R A C T 2 0 2 6 2 0 6 0 5 8 1 4 J u l 2 0 2 6 1 0 0 6 6 7 4 5 7 3

Images